20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
#2102Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
#2103Methods of treating hypertriglyceridemia
#2104PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME
#2105Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#2106Botanical formulations
#2107Oral Composition Comprising DHA and Genistein for Enhancing Skin Properties
#2108Self-emulsifying composition of OMEGA3 fatty acid
#2109Retrovirus-infection inhibitor
#2110Composition for improving membrane composition and functioning of cells
#2111Nutritional supplement composition promoting, increase, development, elevation and activation of “serotonin”
#2112Acyltransferases and uses thereof in fatty acid production
#2113DOCOSAHEXAENOIC ACID FOR THE TREATMENT OF HEART FAILURE
#2114Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
#2115Therapeutic stem cell nutrient composition and uses thereof
#2116Methods of treating hypertriglyceridemia
#2117Compositions and methods for lowering triglycerides
#2118Reduction of risk of obesity
#2119Nutrition containing fat blend
#2120Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
#2121Maternal supplement
#2122Methods of treating impaired glucose metabolism via administration of algal biomass
#2123Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
#2124Composition and Method for Improved Lens Comfort
#2125Compositions containing non-polar compounds
#2126Methods and kits for co-administration of nutritional supplements
#2127Enhanced Natural Colors
#2128Method for placental exfoliation using oxo-arachidonic acid or the like
#2129Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
#2130IMPROVED EMULSIFYING SYSTEM FOR NUTRACEUTICAL COMPOSITIONS
#2131Plant extracts from species and their use
#2132Plant derived seed extract rich in essentially fatty acids derived from L. seed: composition of matter, manufacturing process and use
#2133TOPICAL SKIN CREAM COMPRISING PHOSPHATIDYLCHOLINE DHA AND L-TYROSINE
#2134Krill Extracts for Treatment of Cardiovascular Diseases
#2135OMEGA 3 FATTY ACID FORMULATIONS
#2136USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS
#2137Nutritional compositions with coated lipid globules
#2138Oral formulations of bipolar trans carotenoids
#2139NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE
#2140Bipolar trans carotenoid salts and their uses
#2141NOVEL STATIN PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF TREATMENT
#2142MILK-BASED NUTRITIONAL COMPOSITIONS
#2143Stabilized formulation comprising omega-3 fatty acids for skin care and/or wound care
#2144Composition for treatment of skin
#2145Plant derived seed extract rich in essentially fatty acids derived from L. seed: composition of matter, manufacturing process and use
#2146Metabolic uncoupling therapy
#214714-hydroxy-docosahexaenoic acid compounds
#2148METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#2149HISTONE DEACETYLASE INHIBITORS
#2150Lipid composition for the treatment of skin problems in companion animals
#2151Nutrition composition
#2152THICK PINE NEEDLE EXTRACT COMPOSITION FOR CAPSULATION
#2153Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
#2154Therapeutic Liposomes and Methods For Producing and Using the Same
#2155INGESTIBLE COMPOSITIONS AND PROCESSES OF PREPARATION
#2156Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans
#2157Unsaturated fatty acids as thrombin inhibitors
#2158Kits for nutrition supplementation
#2159POLYSACCHARIDE CAPSULE ENCLOSING A FATTY ACID OIL-CONTAINING EMULSION
#2160Reduction of sterols and other compounds from oils
#2161Probiotic confection and lipid compositions
#2162Method for increasing performance of offspring
#2163BIOLOGICAL OIL COMPOSITION, FORMULATIONS COMPRISING THE OIL COMPOSITION, AND USE THEREOF TO PREVENT OR TREAT CARDIOVASCULAR DISEASE
#2164INFANT OR FOLLOW-ON FORMULA
#2165Method of using punicic acid to enhance immune response and prevent metabolic disorders
#2166POLYUNSATURATED FATTY ACIDS FOR IMPROVING VISION
#2167Stabilized steroid composition and method for its preparation
#2168Polyunsaturated fatty acids interactions and oxidative stress disorders
#2169Supplement composition and method of use
#2170SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME USING OMEGA CHOLINE
#2171PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
#2172METHODS FOR STIMULATING CHONDROGENESIS UTILIZING A POTASSIUM CHANNEL INHIBITOR
#2173Compositions containing non-polar compounds
#2174FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof
#2175DIENE COMPOUNDS FOR USE IN HUMAN EPIDERMAL CELL REPAIR AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
#2176DOCOSAHEXAENOIC ACID BOUND IN PHOSPHOLIPIDS AND METHOD OF RECOVERING SAME FROM A NATURAL SOURCE
#2177COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#2178Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions
#2179SUBSTANCES FOR PROMOTING HEALTHY JOINT FUNCTION COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACIDS OR DRIVATIVES THEREOF, UNDENATURED TYPE II COLLAGEN AND, OPTIONALLY, GLUCOSAMINE SULFATE
#2180Method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosis
#2181Compositions and methods for treating depression
#2182DHA Free Fatty Acid Emulsions
#2183Bipolar trans carotenoid salts and their uses
#2184Compositions and methods for treating varicose veins
#2185Dermo-cosmetic composition for pets
#2186Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
#2187OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME
#2188PLANT EXTRACT AND PUFA COMBINATIONS
#2189Therapeutic agent for hepatitis C
#2190Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#2191Compositions and methods for treating osteoarthritis
#2192CLINICAL BENEFITS OF EICOSAPENTAENOIC ACID IN HUMANS
#2193DOUGH COMPOSITION
#2194Custom-formulated phospholipid microbubbles and methods and uses thereof
#2195METHODS OF TREATING AND PREVENTING NEUROLOGICAL DISORDERS USING DOCOSAHEXAENOIC ACID
#2196Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#2197Topical scar treatment composition
#2198PREVENTION OF PSYCHOTIC DISORDERS AND/OR TREATMENT OF PSYCHOTIC SYMPTOMS
#2199Stability additives for dry DHA dosage forms
#2200GASTRIC THERAPIES AND COMPOSITIONS THEREFOR
#2201THERAPEUTIC AGENT FOR ANCA-RELATED VASCULITIS
#2202Nutritional composition for improving muscle function and daily activity
#2203Nutritional Composition for Improving the Mammalian Immune System
#2204Glycerophospholipids for the improvement of cognitive functions
#2205Compositions and their uses directed to acetyl-CoA carboxylases
#2206INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY
#2207Drink formula comprising fresh marine omega-3 oil and antioxidants
#2208Lipoic acid pellet composition
#2209Methods and Nutritional Formulations to Increase the Efficacy and Reduce the Side Effects of Cancer Treatment
#2210Stabilized formulations of fatty acids
#2211NUTRITIONAL SUPPLEMENTS FOR RELIEF OF DRY EYE
#2212Alleviating oxidative stress disorders with PUFA derivatives
#2213Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
#2214HUMAN BETA3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME
#2215Type a gelatin capsule containing PUFA in free acid form
#2216DIAGNOSIS AND TREATMENT OF HEPATIC DISORDER
#2217STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY
#2218Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids
#2219AGENTS WHICH REGULATE, INHIBIT, OR MODULATE THE ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A UNIQUE MEANS TO BOTH LOWER INTRAOCULAR PRESSURE AND TREAT GLAUCOMATOUS RETINOPATHIES/OPTIC NEUROPATHIES
#2220TAXANE DERIVATIVE CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED THERAPEUTIC EFFICACY
#2221PROPHYLACTIC/AMELIORATING OR THERAPEUTIC AGENT FOR NON-ALCOHOLIC STEATOHEPATITIS
#2222Probiotic Stabilization
#2223METHOD OF SLOWING THE AGING PROCESS BY ACTIVATING SIRTUIN ENZYMES
#2224HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES
#2225Chemosensory receptor ligand-based therapies
#2226USE OF SALSALATE WITH OR WITHOUT CAFFEINE AND WITH OR WITHOUT OMEGA 3, AND OTHER PHARMACEUTICAL COMPOUNDS IN A DISTINCTIVELY UNIQUE NANO-PARTICULATE CAPSULE AND TABLET
#2227DOCOSAHEXANOIC ACID AS INHIBITOR OF H. PYLORI
#2228Lipoxin analogs and methods for the treatment of periodontal disease
#2229Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
#2230USE OF EICOSAPENTAENOIC ACID AND/OR DOCOSAHEXAHENOIC ACID IN WOMEN WITH ENDOMETRIOSIS
#2231SUPPLEMENT FOR REDUCING HIV TRANSMISSION AND METHOD THEREOF
#2232Fatty acid niacin conjugates and their uses
#2233THERAPEUTIC INTERVENTION TO MIMIC THE EFFECT OF CALORIC RESTRICTION
#2234METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF EXENATIDE
#2235Nutritional compositions containing punicalagins
#2236NUTRACEUTICAL COMPOSITION AND METHODS OF USE
#2237PLANT-BASED OMEGA CHEWABLE SUPPLEMENT
#2238ANTI-INFECTIVE ANTIMICROBIAL-CONTAINING BIOMATERIALS
#2239DIETARY SUPPLEMENT COMPOSITIONS FOR CARDIOVASCULAR HEALTH
#2240Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
#2241Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof
#2242SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME
#2243Composition and method to alleviate joint pain
#2244METHOD OF PRODUCING EGG YOLK BASED FUNCTIONAL FOOD PRODUCT AND PRODUCTS OBTAINABLE THEREBY
#2245METHODS OF TREATING NEUROLOGICAL DISEASES USING DOCOSAHEXAENOIC ACID AND ARACHIDONIC ACID COMPOSITIONS
#2246Microcapsules comprising a fat-soluble active substance
#2247Vitamin formulation
#2248Lipid composition for improving brain function
#2249Compositions and methods for the treatment of cancer
#2250USE OF OMEGA-3-FATTY ACID(S)
#2251Supporting activities of daily living
#2252Nitrated lipids and methods of making and using thereof
#2253MEMORY IN SUBJECTS WITH MINI-MENTAL STATE EXAMINATION OF 24-26
#2254Food composition for prodromal dementia patients
#2255METHOD AND COMPOSITION FOR TREATING PULMONARY HEMORRHAGE
#2256Methods of treating hypertriglyceridemia
#2257Reduction of sterols and other compounds from oils
#2258Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
#2259DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells
#2260Botanical anti-acne formulations
#2261Preparation for the prevention and/or treatment of vascular disorders
#2262NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION
#2263Nutraceutical composition and methods of use
#2264COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION
#2265Inflammatory Disease Treatment
#2266Methods Of Use Of Nitroalkene Compositions In Dermatologic Applications
#2267USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS
#2268Stabilized steroid composition and method for its preparation
#2269Linoleic acid active agents for enhancing probability of becoming pregnant
#2270Stable pharmaceutical composition and methods of using same
#2271Preventive or therapeutic drug for Alzheimer-type dementia
#2272STABILITY ADDITIVES FOR DRY DHA DOSAGE FORMS
#2273Methods and compositions for promoting the neurological development of an infant
#2274Alleviating neuropathic pain with EETs and sEH inhibitors
#2275PHARMACEUTICAL COMPOSITION COMPRISING PEROXIDED OIL AND CHOLESTEROL AND USES THEREOF IN MEDICAL FIELD
#2276Method for decreasing cartilage damage in dogs
#2277Compositions containing sesamin-class compound(s) and arachidonic acid class compound(s)
#2278Unit dosage for brain health
#2279Composition comprising polyunsaturated fatty acids and activated charcoal
#2280Kits for nutrition supplementation
#2281Methods for decreasing cartilage damage in dogs
#2282Dietary formulations and methods for treatment of inflammation and other disorders
#2283Nerve Regeneration Promoting Agent
#2284Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
#2285PRODUCT AND USE OF OMEGA-3S MATCHING HUMAN TISSUE RATIOS FOR TREATMENT OF INFLAMMATORY AND OTHER CONDITIONS
#2286Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#2287INGESTIBLE FILM COMPOSITION
#2288COMPOSITIONS COMPRISING UNSATURATED FATTY ACIDS AND NITRIC OXIDE RELEASING COMPOUNDS AND USE THEREOF FOR ENHANCING COGNITIVE AND RELATED FUNCTIONS
#2289GRANULE, TABLET AND METHODS FOR PRODUCING THE SAME
#2290Formulation to improve gastrointestinal function
#2291THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF
#2292Orodispersible composition comprising polyunsaturated fatty acids without bad odor or taste
#2293Methods for making retinoids and uses thereof
#2294METHODS FOR IMPROVING COGNITIVE FUNCTION AND DECREASING HEART RATE
#2295METHODS OF TREATING PSYCHIATRIC, SUBSTANCE ABUSE, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA-3 FATTY ACIDS
#2296Composition and methods for the treatment of cancer
#2297Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#2298ORAL COMPOSITION WITH AN ANTIAGEING EFFECT ON THE SKIN
#2299Cachexia prevention supplement
#2300Protein free formula
#2301BARRIER INTEGRITY IN HIV PATIENTS
#2302Nutraceuticals containing nitro fatty acids
#2303COMPOSITION OF N-3 FATTY ACIDS HAVING HIGH CONCENTRATION OF EPA AND/OR DHA AND CONTAINING N-6 FATTY ACIDS
#2304COMPOSITION AND NUTRITIONAL SUPPLEMENTS FOR IMPROVING OCULAR HEALTH AND REDUCING OCULAR INFLAMMATORY RESPONSE
#2305Drug or Supplement Combination with Conjugated Linoleic Acid for Fat Loss in Mammals
#2306ANTI-INFLAMMATORY COMPOUNDS CONTAINING COMPOSITIONS FOR TREATMENT OF CANCER
#2307Bipolar trans carotenoid salts and their uses
#2308OMEGA 3 FATTY ACID FORMULATIONS
#2309Methods for controlling formation of imiquimod impurities for two months, four months, and six months
#2310Methods for stabilizing imiquimod for two months, four months, and six months
#2311Methods for reducing imiquimod impurities for two months, four months, and six months
#2312Pharmaceutical creams with refined oleic acid
#2313Reduction of imiquimod impurities in pharmaceutical creams
#2314Pharmaceutical creams with reduced imiquimod impurities
#2315Reduction of imiquimod impurities using refined oleic acid
#2316Method of stabilizing imiquimod
#2317NUTRITIONAL FORMULATIONS
#2318Method of treating a mucosal and/or dermal associated condition
#2319Method of treating a dermal and/or mucosal associated condition
#2320Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid
#2321Reduction of imiquimod impurities at four months using refined oleic acid
#2322Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
#2323Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage)
#2324Methods for improving imiquimod availability at two months, four months and six months between refined and compendial
#2325Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator)
#2326Reduction of imiquimod impurities at six months using refined oleic acid
#2327Method of inducing interferon biosynthesis
#2328Reduction of IMIQUIMOD impurities at two months using refined oleic acid
#2329Method of inducing cytokine biosynthesis
#2330Method of treating mollescum contagiosum
#2331Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
#2332Method of treating basal cell carcinoma
#2333Method of controlling formation of imiquimod impurities
#2334Method of treating genital or peri-anal warts
#2335Method of treating actinic keratosis
#2336Method of reducing imiquimod impurity formation
#2337SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING RED YEAST RICE EXTRACT AND OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVE THEREOF
#2338NOVEL USE OF HYDROXYTYROSOL
#2339COMPOSITION FOR PREVENTING OR TREATING THROMBUS- OR EMBOLUS- ASSOCIATED DISEASE
#2340USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS
#2341Fatty acids for use as a medicament
#2342Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
#2343Methods and related compositions using specific flavonoids and indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals
#2344Omega 3 fatty acid formulations
#2345USE OF RESOLVINS AND DOCOSATRIENES AND ANALOGUES THEREOF FOR THE TREATMENT OF ANGIOGENESIS AND OCULAR NEOVASCULARIZATION
#2346USE OF NOVEL LIPID MEDIATORS TO INHIBIT ANGIOGENESIS
#2347Compositions containing PUFA and methods of use thereof
#2348FORMULATION CONTAINING A CARBOXYLIC ACID OR AN ESTER THEREOF
#2349SKIN CARE COMPOSITION
#2350Use of Nutritional Compositions for Preventing Disorders
#2351Probiotic infant products
#2352Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors
#2353Production of ultrapure EPA and polar lipids from largely heterotrophic culture
#2354LIPID-AMINO ACID CONJUGATES AND METHODS OF USE
#2355Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
#2356NUTRITIONAL SUPPLEMENT COMPOSITION FOR TREATMENT OF OCULAR DISEASES
#2357Use of nutritional compositions for preventing disorders
#2358USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND IDENTIFICATION OF ANTI-GLAUCOMA AGENTS
#2359Formulation
#2360RETROVIRUS-INFECTION INHIBITOR
#2361METHODS OF TREATING AND PREVENTING NEOVASCULARIZATION WITH OMEGA-3 POLYUNSATURATED FATTY ACIDS
#2362Method to Reduce Oxidative Damage and Improve Mitochondrial Efficiency
#2363COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUCOSITIS
#2364Composition comprising rutin and polyunsaturated fatty acid having an inhibitory activity on 5 α-reductase
#2365Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease
#2366NUTRITIONAL SUPPLEMENT COMPOSITION FOR TREATMENT OF OCULAR DISEASES
#2367METHOD OF NEUTRALISING ORGANOBORONATES WITH ACIDS
#2368Compositions containing pufa and/or uridine and methods of use thereof
#2369COMPOSITIONS AND METHODS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE
#2370Compositions containing high omega-3 and low saturated fatty acid levels
#2371RESOLVINS: BIOTEMPLATES FOR NOVEL THERAPEUTIC INTERVENTIONS
#2372Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
#2373Statin and omega-3 fatty acids for reduction of Apo-B levels
#2374Nutritional Compositions Containing Punicalagins
#2375COMPOSITION AND USE OF RAR ANTAGONISTS FOR PROMOTING CHONDROGENESIS
#2376Electrical stimulation method for treatment of peripheral neuropathy
#2377ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES
#2378Lipoxin analogs and methods for the treatment of periodontal disease
#2379Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
#2380Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
#2381Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects
#2382Compositions containing non-polar compounds
#2383Compositions containing non-polar compounds
#2384USE OF CALCIUM SALT OF POLYENOIC ACID IN MEDICAL AND COSMETIC FIELD
#2385Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#2386Preventive or Therapeutic Drug for Alzheimer-Type Dementia
#2387Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
#2388HEALING COMPOSITION
#2389PLURIPOTENT THERAPEUTIC COMPOSITIONS AND USES THEREOF
#2390Lipoxin compounds and their use in treating cell proliferative disorders
#2391Activators of peroxisome proliferator-activated receptors
#2392LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF
#2393Compositions and Methods For Preventing or Treating Inflammatory Bowel Disease
#2394METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH
#2395Lipoxin compounds and their use in treating cell proliferative disorders
#2396Plant derived seed extract rich in essentially fatty acids derived from L. seed: composition of matter, manufacturing process and use
#2397Method for preparing compositions for preventing or treating inflammatory bowel disease
#2398Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders
#2399Oral Composition with an Antiageing Effect on the Skin
#2400Statin and Omega-3 Fatty Acids For Lipid Therapy